commercialisation

R&D

LUCENT Biopharma's Medical Director Matthew Goodman, a doctor by training, specialises in late-phase Clinical Development and Medical Affairs.

Market Access

Following Asembia 2026, pharmaphorum spoke with Krista Pinto, a leading commercialisation expert at EVERSANA.

Digital

Predictive AI is not replacing human expertise, but augmenting it.

Sales & Marketing

In this sponsored pharmaphorum podcast, Amanjeet Singh Saluja, a Principal at Axtria, discusses the current state of affairs in launch success.

R&D

As rare disease becomes more competitive, information parity is disappearing.

Market Access

Rare disease launches are the ultimate stress test for European commercialisation.